3,202
Views
18
CrossRef citations to date
0
Altmetric
Review

Bloodstream infections in internal medicine

&
Pages 353-365 | Received 04 Sep 2015, Accepted 05 Jan 2016, Published online: 21 Feb 2016

References

  • United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2012 Revision, Press Release (13 June 2013). http://esa.un.org/unpd/wpp/Documentation/pdf/WPP2012_Press_Release.pdf 2013
  • Heppner HJ, Cornel S, Peter W, Philipp B, Katrin S. Infections in the elderly. Crit Care Clin 2013; 29:757-74; PMID:23830661; http://dx.doi.org/10.1016/j.ccc.2013.03.016
  • Juthani-Mehta M, Quagliarello VJ. Infectious diseases in the nursing home setting: challenges and opportunities for clinical investigation. Clin Infect Dis 2010; 51:931-6; PMID:20822459; http://dx.doi.org/10.1086/656411
  • Beckett CL, Harbarth S, Huttner B. Special considerations of antibiotic prescription in the geriatric population. Clin Microbiol Infect 2015; 21:3-9; PMID:25636920; http://dx.doi.org/10.1016/j.cmi.2014.08.018
  • Bassetti M, Molinari MP, Mussap M, Viscoli C, Righi E. Candidaemia in internal medicine departments: the burden of a rising problem. Clin Microbiol Infect 2013; 19:E281-4; PMID:23414070; http://dx.doi.org/10.1111/1469-0691.12155
  • Odden AJ, Rohde JM, Bonham C, Kuhn L, Malani PN, Chen LM, Flanders SA, Iwashyna TJ. Functional outcomes of general medical patients with severe sepsis. BMC Infect Dis. England 2013; 13:588
  • Rohde JM, Odden AJ, Bonham C, Kuhn L, Malani PN, Chen LM, Flanders SA, Iwashyna TJ. The epidemiology of acute organ system dysfunction from severe sepsis outside of the intensive care unit. J Hosp Med 2013; 8:243-7; PMID:23401431; http://dx.doi.org/10.1002/jhm.2012
  • Pope C, Ziebland S, Mays N. Qualitative research in health care. Analyzing qualitative data. BMJ 2000; 320:114-6; PMID:10625273; http://dx.doi.org/10.1136/bmj.320.7227.114
  • Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-55; http://dx.doi.org/10.1378/chest.101.6.1644
  • Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-10; PMID:11445675; http://dx.doi.org/10.1097/00003246-200107000-00002
  • Karlsson S, Ruokonen E, Varpula T, Ala-Kokko TI, Pettila V. Long-term outcome and quality-adjusted life years after severe sepsis. Crit Care Med 2009; 37:1268-74; PMID:19242321; http://dx.doi.org/10.1097/CCM.0b013e31819c13ac
  • Winters BD, Eberlein M, Leung J, Needham DM, Pronovost PJ, Sevransky JE. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med 2010; 38:1276-83; PMID:20308885
  • Esteban A, Frutos-Vivar F, Ferguson ND, Penuelas O, Lorente JA, Gordo F, Honrubia T, Algora A, Bustos A, García G, et al. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med 2007; 35:1284-9; PMID:17414725; http://dx.doi.org/10.1097/01.CCM.0000260960.94300.DE
  • Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:1093; http://dx.doi.org/10.1086/421946
  • Pfaller MA, Jones RN, Doern GV, Kugler K. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998; 42:1762-70; PMID:9661018
  • Rodríguez-Créixems M, Alcalá L, Muñoz P, Cercenado E, Vicente T, Bouza E. Bloodstream infections: evolution and trends in the microbiology workload, incidence, and etiology, 1985-2006. Medicine (Baltimore) 2008; 87:234-49; http://dx.doi.org/10.1097/MD.0b013e318182119b
  • Sader HS, Jones RN, Andrade-Baiocchi S, Biedenbach DJ. SENTRY Participants Group (Latin America). Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers. Diagn Microbiol Infect Dis 2002; 44:273-80; PMID:12493175; http://dx.doi.org/10.1016/S0732-8893(02)00469-8
  • Lai CC, Chen YH, Lin SH, Chung KP, Sheng WH, Ko WC, Hsueh PR. Changing aetiology of healthcare-associated bloodstream infections at three medical centres in Taiwan, 2000-2011. Epidemiol Infect 2014; 142:2180-5; PMID:25116133; http://dx.doi.org/10.1017/S0950268813003166
  • Albrecht SJ, Fishman NO, Kitchen J, Nachamkin I, Bilker WB, Hoegg C, Samel C, Barbagallo S, Arentzen J, Lautenbach E. Reemergence of gram-negative health care-associated bloodstream infections. Arch Intern Med 2006; 166:1289-94; PMID:16801511; http://dx.doi.org/10.1001/archinte.166.12.1289
  • Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med 2012; 18:263-72; PMID:22480775; http://dx.doi.org/10.1016/j.molmed.2012.03.003
  • Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M, Losito AR, Bartoletti M, Del Bono V, Corcione S, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother 2015; 70:2133-43; PMID:25900159; http://dx.doi.org/10.1093/jac/dkv200
  • Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008; 8:159-66; PMID:18291338
  • Cantón R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, Coque TM. Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008; 14 S1:144-53; PMID:Can't; http://dx.doi.org/10.1111/j.1469-0691.2007.01850.x
  • Bush K. Extended-spectrum β-lactamases in North America, 1987-2006. Clin Microbiol Infect 2008; 14 S1:134-43; PMID:18154537; http://dx.doi.org/10.1111/j.1469-0691.2007.01848.x
  • Cantón R, Coque TM. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 2006; 9:466-75; http://dx.doi.org/10.1016/j.mib.2006.08.011
  • Hawkey PM. Prevalence and clonality of extended-spectrum β-lactamases in Asia. Clin Microbiol Infect 2008; 14 S1:159-65; PMID:18154540; http://dx.doi.org/10.1111/j.1469-0691.2007.01855.x
  • Giani T, Pini B, Arena F, Conte V, Bracco S, Migliavacca R, Pantosti A, Pagani L, Luzzaro F, Rossolini GM. AMCLI-CRE Survey Participants. Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011. Euro Surveill 2013; 18:pii 20489; PMID:23787077
  • Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013; 13:785-96; PMID:23969216; http://dx.doi.org/10.1016/S1473-3099(13)70190-7
  • Endimiani A, Hujer AM, Perez F, Bethel CR, Hujer KM, Kroeger J, Oethinger M, Paterson DL, Adams MD, Jacobs MR, et al. Characterization of blaKPC containing Klebsiella pneumoniae isolates detected in different institutions in the eastern USA. J Antimicrob Chemother 2009; 63:427-37; PMID:19155227; http://dx.doi.org/10.1093/jac/dkn547
  • Ma L, Wang JT, Wu TL, Siu LK, Chuang YC, Lin JC, Lu MC, Lu PL. Emergence of OXA-48-Producing Klebsiella pneumoniae in Taiwan. PLoS ONE 2015; 10: e0139152; PMID:26414183; http://dx.doi.org/10.1371/journal.pone.0139152
  • Corcione S, Rocchetti A, Argentero PA, Raso R, Zotti CM, De Rosa FG, Ghisetti V. A one-year survey of carbapenemase-producing Klebsiella pneumoniae in Italy: beyond the ICU. Clin Microbiol Infect 2015; 21:e11-3; PMID:25682279; http://dx.doi.org/10.1016/j.cmi.2014.09.012
  • Giacobbe DR, Del Bono V, Marchese A, Viscoli C. Early carbapenem-resistant Klebsiella pneumoniae bacteraemia: should we expand the screening? Clin Microbiol Infect 2014; 20(12):O1157-8
  • Alicino C, Giacobbe DR, Orsi A, Tassinari F, Trucchi C, Sarteschi G, Copello F, Del Bono V, Viscoli C, Icardi G. Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a 8-year retrospective study in a large teaching hospital in northern Italy. BMC Infect Dis 2015; 15:415; PMID:26464061; http://dx.doi.org/10.1186/s12879-015-1152-0
  • Bassetti M, Merelli M, Righi E, Diaz-Martin A, Rosello EM, Luzzati R, Parra A, Trecarichi EM, Sanguinetti M, Posteraro B, et al. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol 2013; 51(12):4167-72; PMID:24108614; http://dx.doi.org/10.1128/JCM.01998-13
  • Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009; 48:1695-703; PMID:19441981; http://dx.doi.org/10.1086/599039
  • .Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, Calandra T, Glauser MP, Täuber MG, Pittet D. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis 2004; 38:311-20; PMID:14727199; http://dx.doi.org/10.1086/380637
  • Wisplinghoff H, Ebbers J, Geurtz L, Stefanik D, Major Y, Edmond MB, Wenzel RP, Seifert H. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents 2014; 43:78-81; PMID:24182454; http://dx.doi.org/10.1016/j.ijantimicag.2013.09.005
  • Asmundsdottir LR, Erlendsdottir H, Gottfredsson M. Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland. J Clin Microbiol 2002; 40:3489-92; PMID:12202600; http://dx.doi.org/10.1128/JCM.40.9.3489-3492.2002
  • Luzzati R, Cavinato S, Deiana ML, Rosin C, Maurel C, Borelli M. Epidemiology and outcome of nosocomial candidemia in elderly patients admitted prevalently in medical wards. Aging Clin Exp Res 2014; 27(2):131-7; PMID:24923673
  • Nucci M, Queiroz-Telles F, Alvarado-Matute T, Tiraboschi IN, Cortes J, Zurita J, Guzman-Blanco M, Santolaya ME, Thompson L, Sifuentes-Osornio J, et al. Epidemiology of candidemia in Latin America: a laboratory-based survey. PLoS One 2013; 8:e59373; PMID:23527176; http://dx.doi.org/10.1371/journal.pone.0059373
  • Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). Int J Antimicrob Agents 2011; 38:65-9; PMID:21514797; http://dx.doi.org/10.1016/j.ijantimicag.2011.02.016
  • Falcone M, Concia E, Iori I, Lo Cascio G, Mazzone A, Pea F, Violi F, Venditti M. Identification and management of invasive mycoses in internal medicine: a road-map for physicians. Intern Emerg Med 2014; 9:501-11; PMID:24871636; http://dx.doi.org/10.1007/s11739-014-1077-4
  • High KP. Infection in an ageing world. Lancet Infect Dis 2002; 2:655; PMID:12409042; http://dx.doi.org/10.1016/S1473-3099(02)00434-6
  • Raad I, Hanna H, Boktour M, Girgawy E, Danawi H, Mardani M, Kontoyiannis D, Darouiche R, Hachem R, Bodey GP. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis 2004; 38:1119-27; PMID:15095217; http://dx.doi.org/10.1086/382874
  • Rychly DJ, DiPiro JT. Infections associated with tumor necrosis factor-α antagonists. Pharmacotherapy 2005; 25:1181-92; PMID:16164393; http://dx.doi.org/10.1592/phco.2005.25.9.1181
  • Coburn B, Morris AM, Tomlinson G, Detsky AS. Does this adult patient with suspected bacteremia require blood cultures? JAMA 2012 Aug 1; 308:502-11; http://dx.doi.org/10.1001/jama.2012.8262
  • Stojadinovic O, Brem H, Vouthounis C, Lee B, Fallon J, Stallcup M, Merchant A, Galiano RD, Tomic-Canic M. Molecular pathogenesis of chronic wounds: the role of β-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol 2005; 167:59-69; PMID:15972952; http://dx.doi.org/10.1016/S0002-9440(10)62953-7
  • van der Pouw Kraan TC, Chen WJ, Bunck MC, van Raalte DH, van der Zijl NJ, van Genugten RE, van Bloemendaal L, Baggen JM, Serné EH, Diamant M, et al. Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity. BMC Med Genomics 2015; 8:20; PMID:25956355; http://dx.doi.org/10.1186/s12920-015-0096-y
  • Wong SL, Demers M, Martinod K, Gallant M, Wang Y, Goldfine AB, Kahn CR, Wagner DD. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat Med 2015; 21(7):815-9
  • LoGerfo FW, Coffman JD. Current concepts. Vascular and microvascular disease of the foot in diabetes. Implications for foot care. N Engl J Med 1984; 311:1615-9; PMID:6390204; http://dx.doi.org/10.1056/NEJM198412203112506
  • Noor S, Zubair M, Ahmad J. Diabetic foot ulcer-A review on pathophysiology, classification and microbial etiology. Diabetes Metab Syndr 2015; 9(3):192-9; PMID:25982677
  • Tooke JE, Brash PD. Microvascular aspects of diabetic foot disease. Diabet Med 1996; 13 Suppl 1:S26-9; PMID:8741825
  • Bruns T, Zimmermann HW, Stallmach A. Risk factors and outcome of bacterial infections in cirrhosis. World J Gastroenterol 2014; 20:2542-54; PMID:24627590; http://dx.doi.org/10.3748/wjg.v20.i10.2542
  • Steffen EK, Berg RD, Deitch EA. Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node. J Infect Dis 1988; 157:1032-8; PMID:3283254; http://dx.doi.org/10.1093/infdis/157.5.1032
  • Runyon BA, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 1994; 21:792-6; PMID:7890896; http://dx.doi.org/10.1016/S0168-8278(94)80241-6
  • Scarpellini E, Valenza V, Gabrielli M, Lauritano EC, Perotti G, Merra G, Dal Lago A, Ojetti V, Ainora ME, Santoro M, et al. Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed? Am J Gastroenterol 2010; 105:323-7; PMID:19844200; http://dx.doi.org/10.1038/ajg.2009.558
  • Teltschik Z, Wiest R, Beisner J, Nuding S, Hofmann C, Schoelmerich J, Bevins CL, Stange EF, Wehkamp J. Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense. Hepatology 2012; 55:1154-63; PMID:22095436; http://dx.doi.org/10.1002/hep.24789
  • Alarcon GS. Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis. Infect Dis Clin North Am 2006; 20:849-75; PMID:17118293; http://dx.doi.org/10.1016/j.idc.2006.09.007
  • Marin M, Gudiol C, Garcia-Vidal C, Ardanuy C, Carratala J. Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center. Medicine (Baltimore) 2014; 93:143-9; PMID:24797169; http://dx.doi.org/10.1097/MD.0000000000000026
  • Schelenz S, Nwaka D, Hunter PR. Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance. J Antimicrob Chemother 2013; 68:1431e8; http://dx.doi.org/10.1093/jac/dkt002
  • Marin M, Gudiol C, Ardanuy C, Garcia-Vidal C, Calvo M, Arnan M, Carratalà J. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours. J Infect 2014; 69:417-23; PMID:24960295; http://dx.doi.org/10.1016/j.jinf.2014.05.018
  • Goasguen JE, Bennett JM, Bain BJ, Brunning R, Vallespi MT, Tomonaga M, Zini G, Renault AS. Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res 2014; 38:447-53; PMID:24439566; http://dx.doi.org/10.1016/j.leukres.2013.12.020
  • Steensma DP, Tefferi A. The myelodysplastic syndrome(s): a perspective and review highlighting current controversies. Leuk Res 2003; 27:95-120; PMID:12526916; http://dx.doi.org/10.1016/S0145-2126(02)00098-X
  • Marschall J. Catheter-associated bloodstream infections: looking outside of the ICU. Am J Infect Control. United States 2008:S172 e5-8
  • Rhee Y, Heung M, Chen B, Chenoweth CE. Central line-associated bloodstream infections in non-ICU inpatient wards: a 2-year analysis. Infect Control Hosp Epidemiol 2015; 36:424-30; PMID:25782897; http://dx.doi.org/10.1017/ice.2014.86
  • Tedja R, Gordon SM, Fatica C, Fraser TG. The descriptive epidemiology of central line-associated bloodstream infection among patients in non-intensive care unit settings. Infect Control Hosp Epidemiol 2014; 35:164-8; PMID:24442079; http://dx.doi.org/10.1086/674856
  • Vonberg RP, Behnke M, Geffers C, Sohr D, Ruden H, Dettenkofer M, Gastmeier S. Device-associated infection rates for non-intensive care unit patients. Infect Control Hosp Epidemiol 2006; 27:357-61; PMID:16622812; http://dx.doi.org/10.1086/503339
  • Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355:2725-32; PMID:17192537; http://dx.doi.org/10.1056/NEJMoa061115
  • Trick WE, Vernon MO, Welbel SF, Wisniewski MF, Jernigan JA, Weinstein RA. Unnecessary use of central venous catheters: the need to look outside the intensive care unit. Infect Control Hosp Epidemiol 2004; 25:266-8; PMID:15061422; http://dx.doi.org/10.1086/502390
  • Chopra V, O'Horo JC, Rogers MA, Maki DG, Safdar N. The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 2013; 34:908-18; PMID:23917904; http://dx.doi.org/10.1086/671737
  • Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, Cabell CH, Ramos AI, Fowler V, Jr, Hoen B, et al. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med 2008; 168:2095-103; PMID:18955638; http://dx.doi.org/10.1001/archinte.168.19.2095
  • Wang L, Lansing B, Symons K, Flannery EL, Fisch J, Cherian K, McNamara SE, Mody L. Infection rate and colonization with antibiotic-resistant organisms in skilled nursing facility residents with indwelling devices. Eur J Clin Microbiol Infect Dis 2012; 31:1797-804; PMID:22274858; http://dx.doi.org/10.1007/s10096-011-1504-7
  • Cornejo-Dávila V, Palmeros-Rodríguez MA, Uberetagoyena-Tello de Meneses I, Mayorga-Gómez E, Garza-Sáinz G, Osornio-Sánchez V, et al. Management of complicated urinary tract infections in a referral center in Mexico. Int Urol Nephrol 2015; 47:229-33; http://dx.doi.org/10.1007/s11255-014-0883-y
  • Lee CC, Chen SY, Chang IJ, Chen SC, Wu SC. Comparison of clinical manifestations and outcome of community-acquired bloodstream infections among the oldest old, elderly, and adult patients. Medicine (Baltimore) 2007; 86:138-44; PMID:17505253; http://dx.doi.org/10.1097/SHK.0b013e318067da56
  • Wagenlehner FM, Lichtenstern C, Rolfes C, Mayer K, Uhle F, Weidner W, Weigand MA. Diagnosis and management for urosepsis. Int J Urol 2013; 20:963-70; PMID:23714209
  • Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, Viscoli C. Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One 2011; 6:e24198; PMID:21935385; http://dx.doi.org/10.1371/journal.pone.0024198
  • Rajagopalan S. Serious infections in elderly patients with diabetes mellitus. Clin Infect Dis 2005; 40:990-6; PMID:15824991; http://dx.doi.org/10.1086/427690
  • Luzzati R, Cavinato S, Giangreco M, Grana G, Centonze S, Deiana ML, Biolo G, Barbone F. Peripheral and total parenteral nutrition as the strongest risk factors for nosocomial candidemia in elderly patients: a matched case-control study. Mycoses 2013; 56:664-71; PMID:23675641; http://dx.doi.org/10.1111/myc.12090
  • Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T, Isenberg HD. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol 1994; 32:452-6; PMID:8150956
  • Swindell K, Lattif AA, Chandra J, Mukherjee PK, Ghannoum MA. Parenteral lipid emulsion induces germination of Candida albicans and increases biofilm formation on medical catheter surfaces. J Infect Dis 2009; 200:473-80; PMID:19552524; http://dx.doi.org/10.1086/600106
  • Samonis G, Galanakis E, Ntaoukakis M, Sarchianaki E, Spathopoulou T, Dimopoulou D, Kofteridis DP, Maraki S. Effects of carbapenems and their combination with amikacin on murine gut colonisation by Candida albicans. Mycoses 2013; 56:105-9; PMID:22680984; http://dx.doi.org/10.1111/j.1439-0507.2012.02212.x
  • Samonis G, Gikas A, Anaissie EJ, Vrenzos G, Maraki S, Tselentis Y, Bodey GP. Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob Agents Chemother 1993; 37:51-3; PMID:8431017; http://dx.doi.org/10.1128/AAC.37.1.51
  • Chassagne P, Perol MB, Doucet J, Trivalle C, Menard JF, Manchon ND, Moynot Y, Humbert G, Bourreille J, Bercoff E. Is presentation of bacteremia in the elderly the same as in younger patients? Am J Med 1996; 100:65-70; PMID:8579089; http://dx.doi.org/10.1016/S0002-9343(96)90013-3
  • Jeong SJ, Yoon SS, Han SH, Yong DE, Kim CO, Kim JM. Evaluation of humoral immune response to nosocomial pathogen and functional status in elderly patients with sepsis. Arch Gerontol Geriatr 2014; 58:10-4; PMID:23998496; http://dx.doi.org/10.1016/j.archger.2013.07.001
  • Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis 2002; 2:659-66; PMID:12409046; http://dx.doi.org/10.1016/S1473-3099(02)00437-1
  • Blatteis CM. Age-dependent changes in temperature regulation - a mini review. Gerontology 2012; 58:289-95; PMID:22085834; http://dx.doi.org/10.1159/000333148
  • Gabriel P, Cakman I, Rink L. Overproduction of monokines by leukocytes after stimulation with lipopolysaccharide in the elderly. Exp Gerontol 2002; 37:235-47; PMID:11772509; http://dx.doi.org/10.1016/S0531-5565(01)00189-9
  • Grubeck-Loebenstein B, Berger P, Saurwein-Teissl M, Zisterer K, Wick G. No immunity for the elderly. Nat Med 1998; 4:870; PMID:9701220; http://dx.doi.org/10.1038/nm0898-870b
  • Born J, Uthgenannt D, Dodt C, Nunninghoff D, Ringvolt E, Wagner T, Fehm HL. Cytokine production and lymphocyte subpopulations in aged humans. An assessment during nocturnal sleep. Mech Ageing Dev 1995; 84:113-26; PMID:8788239; http://dx.doi.org/10.1016/0047-6374(95)01638-4
  • Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004; 39:687-99; PMID:15130663; http://dx.doi.org/10.1016/j.exger.2004.01.009
  • Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013; 369:840-51; PMID:23984731; http://dx.doi.org/10.1056/NEJMra1208623
  • Opal SM, Girard TD, Ely EW. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis 2005; 41Suppl 7:S504-12; PMID:16237654; http://dx.doi.org/10.1086/432007
  • Richardson MD. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 2005; 56Suppl 1:i5-i11; PMID:16120635; http://dx.doi.org/10.1093/jac/dki218
  • Chen HC, Lin WL, Lin CC, Hsieh WH, Hsieh CH, Wu MH, Wu JY, Lee CC. Outcome of inadequate empirical antibiotic therapy in emergency department patients with community-onset bloodstream infections. J Antimicrob Chemother 2013; 68:947-53; PMID:23264512; http://dx.doi.org/10.1093/jac/dks475
  • Retamar P, Portillo MM, Lopez-Prieto MD, Rodriguez-Lopez F, de Cueto M, Garcia MV, Gómez MJ, Del Arco A, Muñoz A, Sánchez-Porto A, et al. Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis. Antimicrob Agents Chemother 2012; 56:472-8; PMID:22005999; http://dx.doi.org/10.1128/AAC.00462-11
  • Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, Spanu T, Ambretti S, Ginocchio F, Cristini F, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012; 55:943-50; PMID:22752516; http://dx.doi.org/10.1093/cid/cis588
  • Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008; 36:941-52; PMID:18431284; http://dx.doi.org/10.1097/CCM.0B013E318165BABB
  • Dahaba AA, Rehak PH, List WF. Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis. Intensive Care Med 2003; 29:579-83; PMID:12652350
  • Foushee JA, Hope NH, Grace EE. Applying biomarkers to clinical practice: a guide for utilizing procalcitonin assays. J Antimicrob Chemother 2012; 67:2560-9; PMID:22833636; http://dx.doi.org/10.1093/jac/dks265
  • Burkhardt O, Ewig S, Haagen U, Giersdorf S, Hartmann O, Wegscheider K, Hummers-Pradier E, Welte T. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J 2010; 36:601-7; PMID:20185423; http://dx.doi.org/10.1183/09031936.00163309
  • Charles PE, Dalle F, Aho S, Quenot JP, Doise JM, Aube H, Olsson NO, Blettery B. Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients. Intensive Care Med 2006; 32:1577-83; PMID:16896850; http://dx.doi.org/10.1007/s00134-006-0306-3
  • Hoeboer SH, van der Geest PJ, Nieboer D, Groeneveld AB. The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis. Clin Microbiol Infect 2015; 21:474-81; PMID:25726038; http://dx.doi.org/10.1016/j.cmi.2014.12.026
  • Martini A, Gottin L, Menestrina N, Schweiger V, Simion D, Vincent JL. Procalcitonin levels in surgical patients at risk of candidemia. J Infect 2010; 60:425-30; PMID:20226210; http://dx.doi.org/10.1016/j.jinf.2010.03.003
  • Clancy CJ, Nguyen MH. Finding the “missing 50%” of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 2013; 56:1284-92; PMID:23315320; http://dx.doi.org/10.1093/cid/cit006
  • Del Bono V, Delfino E, Furfaro E, Mikulska M, Nicco E, Bruzzi P, Mularoni A, Bassetti M, Viscoli C. Clinical Performance of the (1,3)-β-D-Glucan Assay in Early Diagnosis of Nosocomial Candida Bloodstream Infections. Clin Vaccine Immunol 2011; 18:2113-7; PMID:21994353; http://dx.doi.org/10.1128/CVI.05408-11
  • Posteraro B, De Pascale G, Tumbarello M, Torelli R, Pennisi MA, Bello G, Maviglia R, Fadda G, Sanguinetti M, Antonelli M. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1–>3)-β-D-glucan assay, Candida score, and colonization index. Crit Care 2011; 15:R249; PMID:22018278; http://dx.doi.org/10.1186/cc10507
  • Cuenca-Estrella M, Verweij PE, Arendrup MC, Arikan-Akdagli S, Bille J, Donnelly JP, Jensen HE, Lass-Flörl C, Richardson MD, Akova M, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 2012; 18 Suppl 7:9-18; PMID:23137134
  • Arendrup MC, Bergmann OJ, Larsson L, Nielsen HV, Jarløv JO, Christensson B. Detection of candidaemia in patients with and without underlying haematological disease. Clin Microbiol Infect 2010; 16:855-62; http://dx.doi.org/10.1111/j.1469-0691.2009.02931.x
  • Prella M, Bille J, Pugnale M, Duvoisin B, Cavassini M, Calandra T, et al. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn Microbiol Infect Dis 2005; 51:95-101; PMID: 15698714; http://dx.doi.org/10.1016/j.diagmicrobio.2004.08.015
  • Mikulska M, Calandra T, Sanguinetti M, Poulain D, Viscoli C; Third European Conference on Infections in Leukemia Group. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care 2010; 14:R222; PMID:21143834; http://dx.doi.org/10.1186/cc9365
  • Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62(4):e1-e50.
  • Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, Sobel JD, Pappas PG, Kullberg BJ. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 2012; 54:1110-22; PMID:22412055; http://dx.doi.org/10.1093/cid/cis021
  • Garnacho-Montero J, Aldabo-Pallas T, Palomar-Martinez M, Valles J, Almirante B, Garces R, Grill F, Pujol M, Arenas-Giménez C, Mesalles E, et al. Risk factors and prognosis of catheter-related bloodstream infection in critically ill patients: a multicenter study. Intensive Care Med 2008; 34:2185-93; PMID:18622596; http://dx.doi.org/10.1007/s00134-008-1204-7
  • Bassetti M, Trecarichi EM, Mesini A, Spanu T, Giacobbe DR, Rossi M, Shenone E, Pascale GD, Molinari MP, Cauda R, et al. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2012; 18:862-9; PMID:21999245; http://dx.doi.org/10.1111/j.1469-0691.2011.03679.x
  • Daikos GL, Tsaousi S, Tzouvelekis LS, Anyfantis I, Psichogiou M, Argyropoulou A, Stefanou I, Sypsa V, Miriagou V, Nepka M, et al. Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems. Antimicrob Agents Chemother 2014; 58:2322-8; PMID:24514083; http://dx.doi.org/10.1128/AAC.02166-13
  • Tumbarello M, De Pascale G, Trecarichi EM, Spanu T, Antonicelli F, Maviglia R, Pennisi MA, Bello G, Antonelli M. Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients. Intensive Care Med 2013; 39:682-92; PMID:23370828; http://dx.doi.org/10.1007/s00134-013-2828-9
  • Papadimitriou-Olivgeris M, Christofidou M, Fligou F, Bartzavali C, Vrettos T, Filos KS, Marangos M, Anastassiou ED. The role of colonization pressure in the dissemination of colistin or tigecycline resistant KPC-producing Klebsiella pneumoniae in critically ill patients. Infection 2014; 42:883-90; PMID:25008195; http://dx.doi.org/10.1007/s15010-014-0653-x
  • Tumbarello M, Trecarichi EM, Tumietto F, Del Bono V, De Rosa FG, Bassetti M, Losito AR, Tedeschi S, Saffioti C, Corcione S, et al. Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2014; 58:3514-20; PMID:24733460; http://dx.doi.org/10.1128/AAC.02373-13
  • Giacobbe DR, Del Bono V, Trecarichi EM, De Rosa FG, Giannella M, Bassetti M, Bartoloni A, Losito AR, Corcione S, Bartoletti M, et al. Risk factors for bloostream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study. Clin Microbiol Infect 2015; 21:1106.e1-8; PMID:26278669
  • Kontopidou F, Giamarellou H, Katerelos P, Maragos A, Kioumis I, Trikka-Graphakos E, Valakis C, Maltezou HC. Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options. Clin Microbiol Infect 2013; 20(2):O117-23
  • Qureshi ZA, Paterson DL, Potoski BA, Kilayko MC, Sandovsky G, Sordillo E, Polsky B, Adams-Haduch JM, Doi Y. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 2012; 56:2108-13; PMID:22252816; http://dx.doi.org/10.1128/AAC.06268-11
  • Paul M, Carmeli Y, Durante-Mangoni E, Mouton JW, Tacconelli E, Theuretzbacher U, Mussini C, Leibovici L. Combination therapy for carbapenem-resistant Gram-negative bacteria. J Antimicrob Chemother 2014; 69:2305-9; PMID:24872346; http://dx.doi.org/10.1093/jac/dku168
  • De Rosa FG, Corcione S, Pagani N, Di Perri G. From ESKAPE to ESCAPE, from KPC to CCC. Clin Infect Dis 2015; 60(8):1289-90; PMID:25537879; http://dx.doi.org/10.1093/cid/ciu1170
  • Papadimitriou-Olivgeris M, Spiliopoulou A, Fligou F, Manolopoulou P, Spiliopoulou I, Vrettos T, Dodou V, Filos KS, Anastassiou ED, Marangos M, et al. Association of KPC-producing Klebsiella pneumoniae colonization or infection with Candida isolation and selection of non-albicans species. Diagn Microbiol Infect Dis 2014; 80:227-32; PMID:25175179; http://dx.doi.org/10.1016/j.diagmicrobio.2014.07.012
  • Schechner V, Kotlovsky T, Kazma M, Mishali H, Schwartz D, Navon-Venezia S, Schwaber MJ, Carmeli Y. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? Clin Microbiol Infect 2013; 19:451-6; PMID:22563800; http://dx.doi.org/10.1111/j.1469-0691.2012.03888.x
  • Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008; 52:1028-33; PMID:18086836; http://dx.doi.org/10.1128/AAC.01020-07
  • Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 2012; 18 Suppl 7:19-37; PMID:23137135; http://dx.doi.org/10.1111/1469-0691.12039
  • Laupland KB, Kirkpatrick AW, Delaney A. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med 2007; 35:2686-2692; PMID:18074465; http://dx.doi.org/10.1097/01.CCM.0000295312.13466.1C
  • Vincent JL. Emerging therapies for the treatment of sepsis. Curr Opin Anaesthesiol 2015; 28:411-6; PMID:26087275; http://dx.doi.org/10.1097/ACO.0000000000000210
  • Deresinski S. Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical data. Clin Infect Dis 2007; 45 Suppl 3:S177-83; PMID:17712744; http://dx.doi.org/10.1086/519472
  • Giacobbe DR, Esteves P, Bruzzi P, Mikulska M, Furfaro E, Mesini A, Tatarelli P, Grignolo S, Viscoli C, Colombo AL, et al. Initial serum (1,3)-β-D-glucan as a predictor of mortality in proven candidemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil. Clin Microbiol Infect 2015; 21:954.e9-954.e17; PMID:26070961
  • Jaijakul S, Vazquez JA, Swanson RN, Ostrosky-Zeichner L. (1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis. Clin Infect Dis 2012; 55:521-6; PMID:22573851; http://dx.doi.org/10.1093/cid/cis456
  • Hamilton KW, Fishman NO. Antimicrobial stewardship interventions: thinking inside and outside the box. Infect Dis Clin North Am 2014; 28:301-13; PMID:24857395; http://dx.doi.org/10.1016/j.idc.2014.01.003
  • Charani E, Cooke J, Holmes A. Antibiotic stewardship programmes–what's missing? J Antimicrob Chemother 2010; 65:2275-7; PMID:20851812; http://dx.doi.org/10.1093/jac/dkq357

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.